These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33323965)

  • 1. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
    Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G9a Is SETting the Stage for Colorectal Oncogenesis.
    Bergin CJ; Benoit YD
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32512705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.
    Cha ST; Tan CT; Chang CC; Chu CY; Lee WJ; Lin BZ; Lin MT; Kuo ML
    Nat Cell Biol; 2016 Sep; 18(9):993-1005. PubMed ID: 27525719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
    Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
    Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
    Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
    Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.
    Nachiyappan A; Gupta N; Taneja R
    FEBS J; 2022 Mar; 289(5):1329-1351. PubMed ID: 34954891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
    Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
    Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
    Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
    Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
    Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
    Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low G9a expression is a tumor progression factor of colorectal cancer via IL-8 promotion.
    Ichikawa Y; Takahashi H; Chinen Y; Arita A; Sekido Y; Hata T; Ogino T; Miyoshi N; Uemura M; Yamamoto H; Mizushima T; Doki Y; Eguchi H
    Carcinogenesis; 2022 Sep; 43(8):797-807. PubMed ID: 35640269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
    Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
    Oncotarget; 2015 Feb; 6(5):2917-27. PubMed ID: 25595900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIX-01294 enhances the effect of chemotherapy on colorectal cancer by inhibiting the expression of stemness genes.
    Liu S; Jiang Y; Yang H; Hua Z; Han Y; Zhou C; Xu S; Nie S; Xu G; Shu X; Wang X
    Biochem Biophys Res Commun; 2022 Jan; 590():169-176. PubMed ID: 34979318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors.
    Bergin CJ; Zouggar A; Mendes da Silva A; Fenouil T; Haebe JR; Masibag AN; Agrawal G; Shah MS; Sandouka T; Tiberi M; Auer RC; Ardolino M; Benoit YD
    Nat Cancer; 2024 Mar; 5(3):463-480. PubMed ID: 38351181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
    Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
    Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis.
    Tu WB; Shiah YJ; Lourenco C; Mullen PJ; Dingar D; Redel C; Tamachi A; Ba-Alawi W; Aman A; Al-Awar R; Cescon DW; Haibe-Kains B; Arrowsmith CH; Raught B; Boutros PC; Penn LZ
    Cancer Cell; 2018 Oct; 34(4):579-595.e8. PubMed ID: 30300580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.